Treatment for substance use disorders is complex and multifaceted—all the more so for patients who are pregnant. Join the Betty Ford Center’s Alta DeRoo, MD, an OB-GYN and addiction medicine physician, to learn more about substance use disorder treatment considerations and options during pregnancy. In particular, Dr. DeRoo will focus on maternal and fetal health implications related to the use of opioids, alcohol, methamphetamine and marijuana.
- Learn the standard of care for treatment of opioid use disorder in pregnancy
- Describe the effects of alcohol on the developing fetus
- Identify the effects of methamphetamine and marijuana on the developing fetal brain
Can't attend on the scheduled date?
Register anyway and you'll receive notice when we post the recording for on-demand viewing.
A certificate of completion will be awarded for attending this event. Please note, this event has not been approved for continuing education (CE) credit. The participant is responsible to verify if this activity meets their continuing education board requirements in order to gain credit.
A board certified addiction medicine physician and OBGYN, Alta DeRoo, MD, FASAM, FACOG, serves as medical director of the Betty Ford Center’s three facilities in California, located in Rancho Mirage, West Los Angeles and San Diego. Following a 24-year service career in the U.S. Military, Dr. DeRoo brought her addiction medicine and OBGYN expertise to the civilian sector. She specializes in treating patients with an opioid use disorder as well as pregnant women needing medication-assisted treatment. Dr. DeRoo is a member of the American Society of Addiction Medicine, American Association of Addiction Psychiatry and American College of Obstetricians and Gynecologists.
15245 Pleasant Valley Rd, Center City, MN 55012